Skip to main content

Table 3 Estimates and inferences from the multiple logistic random-intercept models predicting the chance of non-adherence

From: Examining assumptions regarding valid electronic monitoring of medication therapy: development of a validation framework and its application on a European sample of kidney transplant patients

Outcome variable

Parameter

Estimate

Standard error

Odds ratio (95% confidence interval)

DF

t value

p value

Omitted intakes

Random-intercepts variance

2.845

0.445

 

241

6.39

< .0001

 

Intercept

-5.900

0.470

 

241

-12.54

< .0001

 

Exposure to EM (per month)

0.270

0.055

1.31 (1.17–1.46)

241

4.91

< .0001

 

Bottle size (per 100 ml)

0.014

0.040

1.01 (0.94–1.10)

241

0.93

0.35

 

Influence perception

0.277

0.328

1.32 (0.69–2.52)

241

0.84

0.39

 

Interviewer 1 vs. interviewer 4

0.461

0.356

1.59 (0.79–3.19)

241

1.29

0.19

 

Interviewer 2 vs. interviewer 4

0.011

0.365

1.01 (0.50–2.07)

241

0.03

0.97

 

Interviewer 3 vs. interviewer 4

0.022

0.438

1.02 (0.43–2.42)

241

0.05

0.95

Intake variability

Random-intercepts variance

3.486

0.422

 

241

8.26

< .0001

 

Intercept

-3.033

0.414

 

241

-7.31

< .0001

 

Exposure to EM (per month)

0.227

0.036

1.26 (1.17–1.35)

241

6.67

< .0001

 

Bottle size (per 100 ml)

-0.106

0.037

0.90 (0.84–0.97)

241

-2.08

0.04

 

Influence perception

0.011

0.314

1.01 (0.54–1.88)

241

0.04

0.97

 

Interviewer 1 vs. interviewer 4

0.704

0.340

2.02 (1.04–3.95)

241

2.07

0.04

 

Interviewer 2 vs. interviewer 4

0.008

0.344

1.01 (0.51–1.99)

241

0.02

0.98

 

Interviewer 3 vs. interviewer 4

0.148

0.422

1.16 (0.50–2.67)

241

0.35

0.73